Child pages
  • Serial Non-contrast Non-gated T2w MRI Datasets of Patient-derived Xenograft Cancer Models for Development of Tissue Characterization Algorithms (PDMR-Texture-Analysis)

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 28 Next »

Summary

This collection contains serial non-contrast non-gated T2w MRI of 18 patient derived xenograft cancer models (514 images) for researchers to develop algorithms using neural networks, and classification techniques to improve tissue characterization (morphological changes) for the improvement in patient care through advances in precision medicine.

Characterization of tissue using non-invasive in vivo imaging techniques is used for detection and measurement of disease burden in oncology. Researchers have developed numerous algorithms, such as neural networks, and classification techniques to improve the characterization (morphological changes) of tissue. Unfortunately, to obtain statistical significance, large datasets are a requirement in this research endeavor due to tumor heterogeneity within the same histologic classification. Pre-clinical patient derived xenograft animal models can be a significant resource by providing collections with a more homogenous tumor genome across the collection with companion genomic and pathologic characterization available (https://pdmr.cancer.gov/), allowing determination of the variability of imaging characteristics.

This dataset of a patient derived xenograft model (below table) can be used for training algorithms for evaluating variations in tissue texture with respect to tumor growth and cancer model.

PDX Model Characterizations and Biweekly imaging sessions 



Characterization

1

2

3

4

5

6

7

8

Model  ID

CTEP SDC Description

Implant Date

Passage

Gender

# Mice imaged per biweekly imaging session

144126-210-T

Neuroendocrine cancer, NOS

2/14/2020

4

M

8

8

5

5

5

5



146476-266-R

Urothelial/bladder cancer, NOS

2/3/2020

4

M

17

16

13

10

11

4

4


165739-295-R

Adenocarcinoma-pancreas

5/4/2018

2

M

10

10

1






172845-121-T

Adenocarcinoma-colon

10/16/2020

4

F

20

20







172845-142-T

Adenocarcinoma-colon

8/24/2018

3

F

15

13

8

3





287954-098-R

Ewing sarcoma/Peripheral PNET

3/18/2021

6

M

10

8

1

1

1




466636-057-R

Adenocarcinoma-pancreas

12/15/2017

N/A

M

5

4

2

1





521955-158-R4

Adenocarcinoma-pancreas

9/30/2021

4

F

10

10

10

8

5

1

1


521955-158-R6

Adenocarcinoma-pancreas

3/27/2018

N/A

F

7

7

4






625472-104-R  

Adenocarcinoma-colon

8/27/2019

2

F

9

1







695669-166-R

Melanoma

4/16/2021

3

M

7

8

8

6

4

4

2

2

698357-238-R

Osteosarcoma

3/5/2021

6

F

7

4







765638-272-R

Squamous cell lung carcinoma

3/26/2021

4

F

7

8

5

3

1




779769-127-R

Adenocarcinoma-rectum

2/19/2020

5

F

5

5

5

5

3

4



833975-119-R

Adenocarcinoma-pancreas

10/23/2019

2

F

12

12

11

7





894883-131-R

Squamous cell carcinoma-anus

2/25/2022

5

F

6

6

6

1

1




997537-175-T

Adenocarcinoma-colon

10/25/2018

3

M

9

2







BL0382-F1232

Urothelial/bladder cancer, NOS

5/20/2020

4

F

9

6

4

1

1





In this study we performed non-contrast non-gated T2w MRI (SOP50101_MRI), initiated 2 weeks post implantation, and continued biweekly imaging sessions until their tumors reached a size requiring humane termination (ACUC guidance > 2 cm in any linear dimension by caliper or MRI measurement) or their clinical status required euthanasia. Fragments (2x2x2 mm3) from the NCI/DCTD PDMR repository were implanted into 5-10 donor mice (NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ (NSG)). When tumors reached enrollment criteria (100 – 300 mm3), tumors were excised, cut into 2x2x2 mm3 fragments and implanted with Matrigel (per PDMR SOP50101_Tumor Implantation) into NSG study mice. The multi-mouse non-gated DICOM dataset was split according to the method published in Tomography and retained their individual mouse DICOM header information.  Structured Reports (SR) were added to the dataset to include fragment implant date, CTEP description, mouse strain (NSG) and model.

The genomic and pathologic characteristics of these models, which is available from the National Cancer Institute Patient-Derived Models Repository (https://pdmr.cancer.gov/), can be used in conjunction with this publicly available dataset to guide the development of algorithms for enhanced characterization of tissue for precision medicine.

Summary:

This collection contains serial non-contrast T2w MRI of 18 patient derived xenograft cancer models (514 images) for researchers to develop various algorithms using neural networks, and classification techniques to improve tissue characterization (morphological changes). The genomic and pathologic characteristics of these models, which is available from the National Cancer Institute Patient-Derived Models Repository (https://pdmr.cancer.gov/), can be used in conjunction with this publicly available dataset to guide their development of algorithms for enhanced characterization of tissue for precision medicine.


Acknowledgements

We would like to acknowledge the individuals and institutions that have provided data for this collection:

  • Frederick National Laboratory for Cancer Research – Special Thanks to Joseph D. Kalen, PhD, Lilia V. Ileva, MS, Lisa A Riffle, Nimit L Patel, MS, Keita Saito, PhD, Yvonne Evrard, PhD, Justin Smith, Simone Difilippantonio, PhD, Chelsea Sanders, Lai Thang, Ulrike Wagner, Yanling Liu, PhD, John B. Freymann, Justin Kirby and Brenda Fevrier-Sullivan
  • Division of Cancer Therapeutics and Diagnosis/National Cancer Institute - James L. Tatum, MD, Paula M Jacobs, PhD, Melinda G. Hollingshead, DVM, and James H. Doroshow, MD
  • PixelMed Publishing – Special Thanks to David A. Clunie, MD
  • University of Arkansas for Medical Sciences – Special Thanks to Kirk E. Smith 
  • This project has been funded in whole or in part with Federal funds from the National Cancer Institution, National Institutes of Health, under Contract Number HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.


Data Access

Data TypeDownload all or Query/FilterLicense

Images (DICOM, 11.8 GB)

   

(Download requires NBIA Data Retriever)

Standard Operating Procedure 50101: MRI T2 Weighted Non-Contrast Protocol Single Mouse Pulmonary Gated and Multi-Mouse Non-Gated

Standard Operating Procedure 50101: Tumor_Implantation_PDX

PDX Model Characterizations

Data related to specific models in the collection at NCI Patient-Derived Models Repository (PDMR)

Click the Versions tab for more info about data releases.

Additional Resources for this Dataset

The National Cancer Institute (NCI) has developed a national repository of Patient-Derived Models (PDMs) comprised of patient-derived xenografts (PDXs), in vitro patient-derived tumor cell cultures (PDCs) and cancer associated fibroblasts (CAFs) as well as patient-derived organoids (PDOrg). These models serve as a resource for public-private partnerships and for academic drug discovery efforts. These PDMs are clinically-annotated with molecular information and made available in the Patient-Derived Model Repository.  


Detailed Description

Image Statistics

Radiology Image Statistics

Modalities

MR, SR

Number of Patients

175

Number of Studies

689

Number of Series

1203

Number of Images

19343

Images Size (GB)11.8

In addition to images, this collection includes Raw Data Storage SOP Class instances with MR Modality, generated by a Philips MR scanner; this data is not useful to anyone without the proprietary software to interpret it.

Citations & Data Usage Policy

Users must abide by the TCIA Data Usage Policy and Restrictions. Attribution should include references to the following citations:

Data Citation

Kalen, J. D., Ileva, L. V., Riffle, L. A., Keita, S., Tatum, J. L., Jacobs, P. M., Sanders, C., James, A., Difilippantonio, S., Thang, L., Hollingshead, M. G., Evrard, Y., Clunie, D. A., Miao, T., Wagner, U., Freymann, J., Kirby, J., & Doroshow, J. H. (2023). Serial Non-contrast Non-gated T2w MRI Datasets of Patient Derived Xenograft Cancer Models for Development of Tissue Characterization Algorithms (PDMR-Texture Analysis) (Version 1) [Data set]. The Cancer Imaging Archive. https://doi.org/10.7937/3KQ0-YK19

TCIA Citation

Clark, K., Vendt, B., Smith, K., Freymann, J., Kirby, J., Koppel, P., Moore, S., Phillips, S., Maffitt, D., Pringle, M., Tarbox, L., & Prior, F. (2013). The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository. In Journal of Digital Imaging (Vol. 26, Issue 6, pp. 1045–1057). Springer Science and Business Media LLC. https://doi.org/10.1007/s10278-013-9622-7

Other Publications Using This Data

TCIA maintains a list of publications which leverage TCIA data. If you have a manuscript you'd like to add please contact the TCIA Helpdesk.

  • Kalen, J. D., Clunie, D. A., Liu, Y., Tatum, J. L., Jacobs, P. M., Kirby, J., Freymann, J. B., Wagner, U., Smith, K. E., Suloway, C., & Doroshow, J. H. (2021). Design and Implementation of the Pre-Clinical DICOM Standard in Multi-Cohort Murine Studies. Tomography (Ann Arbor, Mich.), 7(1), 1–9. https://doi.org/10.3390/tomography7010001

Version 1 (Current): Updated 2023/06/XX

Data TypeDownload all or Query/FilterLicense

Images (DICOM, 11.8 GB)

    (Download requires the NBIA Data Retriever)

Standard Operating Procedure 50101: MRI T2 Weighted Non-Contrast Protocol Single Mouse Pulmonary Gated and Multi-Mouse Non-Gated

Standard Operating Procedure 50101: Tumor_Implantation_PDX

PDX Model Characterizations

Data related to specific models in the collection at NCI Patient-Derived Models Repository (PDMR)



  • No labels